Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.

Clotting Factor VII activity emerges as a highly significant predictive factor for development of cardiovascular disease (CVD) in prospective trials. We have previously shown that in hypertriglyceridemic individuals a fraction of their clotting Factor VII molecules is present in an activated state in phospholipase C-sensitive complexes in plasma. These complexes may explain the increased Factor VII activity observed to be a predictive factor for CVD. We demonstrate here that the level of such complexes is amenable to dietary intervention and that the alteration in Factor VII complex levels correlates closely with the corresponding alteration in triglycerides.

[1]  I. Holme,et al.  Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals. , 2009, Acta medica Scandinavica.

[2]  P Smith,et al.  FACTOR VII-PHOSPHOLIPID COMPLEX IN MALE SURVIVIRS OF ACUTE MYCORDIAL INFARCTION , 2009, Thrombosis and Haemostasis.

[3]  G. Assmann,et al.  COAGULATION FACTORS AND THE PROGRESS OF CORONARY HEART DISEASE , 1987, The Lancet.

[4]  H. Prydz,et al.  A new form of coagulation factor VII in plasma. , 2009, Scandinavian Journal of Haematology.

[5]  W. H. Wilkinson,et al.  Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality. , 1986, Atherosclerosis.

[6]  L. Carlson,et al.  Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. , 2009, Acta medica Scandinavica.

[7]  M. Blombäck,et al.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.

[8]  I. Hjermann,et al.  A novel form of factor VII in plasma from men at risk for cardiovascular disease , 1985, British journal of haematology.

[9]  S. Thompson,et al.  Assay of factor VII activity by two techniques: evidence for increased conversion of VII to αVIIa in hyperlipidaemia, with possible implications for ischaemic heart disease , 1985, British journal of haematology.

[10]  H. Prydz,et al.  The coagulation factor VII in pregnancy , 1984, British journal of haematology.

[11]  H. Prydz,et al.  Phospholipase C from Bacillus cereus has sphingomyelinase activity. , 1982, Scandinavian journal of clinical and laboratory investigation.

[12]  T W Meade,et al.  Haemostatic function and ischaemic heart disease. , 1981, Lancet.

[13]  S. Thompson,et al.  HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY , 1980, The Lancet.

[14]  S. Thompson,et al.  Haemostatic function and cardiovascular death: early results of a prospective study. , 1980, Lancet.

[15]  C. Little,et al.  A simple purification scheme yielding crystalline phospholipase C from Bacillus cereus. , 1980, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry.

[16]  C. Little,et al.  Purification by affinity chromatography of phospholipase C from Bacillus cereus , 1975, FEBS letters.

[17]  I. Holme,et al.  The Oslo study. Cardiovascular disease in middle-aged and young Oslo men. , 1975, Acta medica Scandinavica. Supplementum.

[18]  H. Prydz,et al.  Studies on tissue thromboplastin: I. Solubilization with sodium deoxycholate , 1966 .

[19]  P. Hjort.  Intermediate reactions in the coagulation of blood with tissue thromboplastin; convertin, accelerin, prothrombinase. , 1957, Scandinavian journal of clinical and laboratory investigation.